Complete Up To Date Information about A-H-Tablets 100 mg.
NADA Number: 006-602 | |
| Proprietary Name |
A-H-Tablets 100 mg A-H-Tablets 25 mg |
|---|---|
| Sponsor |
Schering-Plough Animal Health Corp. |
| Sponsor Address |
P.O. Box 21 Sandown Village, NJ 3171 VIC Australia |
| Ingredients |
Doxylamine Succinate |
| Species |
Horse, not for meat production Cat, no use class stated or implied Dog, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet |
| Drug Form |
Tablet |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
520.784 Doxylamine succinate tablets. Specifications: The drug is in tablet form and contains doxylamine succinate as the active drug ingredient. Conditions of use: Horses Amount: It is administered orally to horses at a dosage level of 1 to 2 milligrams per pound of body weight per day divided into 3 or 4 equal doses. Indications: The drug is used in conditions in which antihistaminic therapy may be expected to alleviate some signs of disease. Limitations: Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Dogs Amount: It is administered orally to dogs at a dosage level of 2 to 3 milligrams per pound of body weight per day divided into 3 or 4 equal doses. Indications: The drug is used in conditions in which antihistaminic therapy may be expected to alleviate some signs of disease. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Cats Amount: It is administered orally to cats at a dosage level of 2 to 3 milligrams per pound of body weight per day divided into 3 or 4 equal doses. Indications: The drug is used in conditions in which antihistaminic therapy may be expected to alleviate some signs of disease. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. NAS/NRC status: These conditions are NAS/NRC reviewed and deemed effective. Applications for these uses need not include effectiveness data as specified by 514.111 of this chapter. |